We are live on !
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.3B
AUM Growth
+$309M
(+3.1%)
Cap. Flow
-$203M
Cap. Flow % of AUM
Cap. Flow %
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
981
New
70
Increased
333
Reduced
365
Closed
69
Avg Time Held
4.4
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVID
Avid Technology Inc
AVID
|
+$16.3M |
| 2 |
Assured Guaranty
AGO
|
+$14.9M |
| 3 |
Crane NXT
CXT
|
+$13.8M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$13.1M |
| 5 |
Bankunited
BKU
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIRCOR International, Inc
CIR
|
+$42.4M |
| 2 |
First Citizens BancShares
FCNCA
|
+$39.3M |
| 3 |
FRG
Franchise Group, Inc.
FRG
|
+$31.1M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$17.2M |
| 5 |
Ares Management
ARES
|
+$17.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.83% |
| 2 | Technology | 19.34% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Financials | 12.33% |
| 5 | Materials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
First Advantage
FA
$3.29B
| $663K | 0.01% |
43,040
-124,170
| -74% | -$1.67M |
2023 Q1
1 quarter
|
|
802
DELISTED
American Woodmark
AMWD
| $652K | 0.01% |
+8,542
| New | +$496K |
2023 Q2
0 quarters
|
|
803
Sturm, Ruger & Co
RGR
$693M
| $652K | 0.01% |
12,302
-2,899
| -19% | -$158K |
2023 Q1
1 quarter
|
|
|
AVTA
804
DELISTED
Avantax, Inc. Common Stock
AVTA
| $647K | 0.01% |
+28,918
| New | +$681K |
2023 Q2
0 quarters
|
|
805
DELISTED
Semler Scientific
SMLR
| $637K | 0.01% |
24,263
+887
| +4% | +$23.4K |
2021 Q3
7 quarters
|
|
806
Magnera Corp
MAGN
$393M
| $635K | 0.01% |
16,185
| – | – |
2019 Q1
17 quarters
|
|
807
Otter Tail
OTTR
$3.78B
| $635K | 0.01% |
+8,037
| New | +$603K |
2023 Q2
0 quarters
|
|
808
DELISTED
Zynex
ZYXI
| $629K | 0.01% |
65,558
-5,623
| -8% | -$58.4K |
2022 Q2
4 quarters
|
|
809
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $626K | 0.01% |
26,435
-340,725
| -93% | -$7.94M |
2022 Q4
2 quarters
|
|
810
WaFd
WAFD
$2.16B
| $619K | 0.01% |
+23,341
| New | +$646K |
2023 Q2
0 quarters
|
|
811
Cytek Biosciences
CTKB
$682M
| $617K | 0.01% |
72,280
+27,866
| +63% | +$250K |
2023 Q1
1 quarter
|
|
812
Nu Skin
NUS
$250M
| $611K | 0.01% |
18,396
-1,163
| -6% | -$42.8K |
2023 Q1
1 quarter
|
|
813
DELISTED
Theravance Biopharma
TBPH
| $611K | 0.01% |
59,009
| – | – |
2014 Q2
36 quarters
|
|
814
Pediatrix Medical
MD
$2.22B
| $605K | 0.01% |
+42,590
| New | +$598K |
2023 Q2
0 quarters
|
|
815
Laureate Education
LAUR
$5.32B
| $604K | 0.01% |
50,000
| – | – |
2023 Q1
1 quarter
|
|
816
DELISTED
Emcore Corp
EMKR
| $593K | 0.01% |
78,840
-285
| -0.4% | -$2.58K |
2013 Q2
40 quarters
|
|
817
1-800-Flowers.com
FLWS
$177M
| $593K | 0.01% |
76,000
-23,842
| -24% | -$219K |
2021 Q2
8 quarters
|
|
818
CryoPort
CYRX
$853M
| $590K | 0.01% |
34,198
| – | – |
2017 Q3
23 quarters
|
|
819
DELISTED
WideOpenWest
WOW
| $584K | 0.01% |
69,215
+16,915
| +32% | +$153K |
2022 Q4
2 quarters
|
|
820
La-Z-Boy
LZB
$1.2B
| $583K | 0.01% |
+20,347
| New | +$568K |
2023 Q2
0 quarters
|
|
821
Charles Schwab
SCHW
$159B
| $582K | 0.01% |
10,270
-4,401
| -30% | -$231K |
2013 Q2
40 quarters
|
|
822
DELISTED
Anywhere Real Estate
HOUS
| $580K | 0.01% |
86,842
-740,809
| -90% | -$4.44M |
2019 Q2
16 quarters
|
|
823
Tvardi Therapeutics
TVRD
$13.5M
| $573K | 0.01% |
5,619
| – | – |
2021 Q3
7 quarters
|
|
824
Innovative Solutions & Support
IA
$346M
| $565K | 0.01% |
78,828
| – | – |
2013 Q2
40 quarters
|
|
825
Octave Specialty Group
OSG
$210M
| $560K | 0.01% |
39,345
+6,527
| +20% | +$95.5K |
2023 Q1
1 quarter
|
|
Similar funds
Royce & Associates's Q2 2023 Portfolio in Review
As of Q2 2023, Royce & Associates held 981 positions worth $10.3B, up 3.1% from $10B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Royce & Associates's Q2 2023 filing shows 70 new, 333 increased, 365 reduced and 69 closed positions. Its largest new stake was Equity Commonwealth: 620,020 shares worth $12.6M. The largest sale was CIRCOR International, Inc, an estimated $42.4M.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2023 buy was Equity Commonwealth: 620,020 shares worth $12.6M.
- Royce & Associates added most to Avid Technology Inc in Q2 2023, an estimated $16.3M increase.
- Royce & Associates's biggest Q2 2023 reduction was First Citizens BancShares, cutting an estimated $39.3M.
- Royce & Associates fully exited CIRCOR International, Inc in Q2 2023, selling an estimated $42.4M.
- Royce & Associates's ten largest holdings make up 9.1% of its $10.3B portfolio in Q2 2023.
- Royce & Associates opened 70 new positions and closed 69 in Q2 2023.
- Royce & Associates's portfolio value rose 3.1% quarter-over-quarter to $10.3B.
Based on Royce & Associates's 13F filing for Q2 2023, filed 7 Aug 2023.